Correlation between insulin albumin and free fatty acids of insulin glargine 300 U/mL and insulin degludec in patients with type 2 diabetes
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000037941
- Lead Sponsor
- Minami Osaka Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 24
Not provided
1. Patients with a history of severe ketosis, diabetic coma or precoma within 6 weeks 2. Patients who developed severe hypoglycemia (diabetic coma or precoma, convulsions requiring third party assistance) within 6 weeks 3. Patients with severe renal dysfunction (eGFR less than 30mL/min/1.73m2 or serum creatinine level above 2.0mg/dL) or endstage renal failure patients on dialysis 4. Patients with proliferative retinopathy (however, patients who have undergone photocoagulation and have stable symptoms can be included) 5. Patients with a history of severe gastrointestinal tract surgery 6. Pregnant women or women who may be pregnant and breastfeeding patients 7. Patients with severe infections, before and after surgery, and severe trauma 8. Patients receiving systemic corticosteroids 9. Patients with severe liver dysfunction (AST or ALT higher than 100U/l) 10. Patients with a history of allergies to the drug to be used for research 11. Patients with malignant tumor or history of malignant tumor 12. Other patients judged by the investigator as inappropriate as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method